Renaissance Technologies’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-278,400
Closed -$108K 3938
2020
Q1
$108K Buy
278,400
+37,686
+16% +$14.6K ﹤0.01% 3214
2019
Q4
$99K Sell
240,714
-288,261
-54% -$119K ﹤0.01% 3328
2019
Q3
$1.06M Sell
528,975
-38,673
-7% -$77.4K ﹤0.01% 2570
2019
Q2
$1.23M Sell
567,648
-53,300
-9% -$115K ﹤0.01% 2596
2019
Q1
$1.96M Sell
620,948
-97,100
-14% -$307K ﹤0.01% 2313
2018
Q4
$1.79M Sell
718,048
-21,200
-3% -$52.8K ﹤0.01% 2291
2018
Q3
$2.97M Buy
739,248
+133,825
+22% +$538K ﹤0.01% 2085
2018
Q2
$2.29M Buy
605,423
+76,510
+14% +$289K ﹤0.01% 2200
2018
Q1
$1.23M Buy
528,913
+42,300
+9% +$98.1K ﹤0.01% 2573
2017
Q4
$754K Buy
486,613
+75,200
+18% +$117K ﹤0.01% 2771
2017
Q3
$876K Buy
411,413
+60,700
+17% +$129K ﹤0.01% 2615
2017
Q2
$1.59M Buy
350,713
+97,300
+38% +$440K ﹤0.01% 2380
2017
Q1
$763K Buy
253,413
+38,400
+18% +$116K ﹤0.01% 2635
2016
Q4
$593K Buy
215,013
+52,400
+32% +$145K ﹤0.01% 2721
2016
Q3
$509K Buy
162,613
+72,400
+80% +$227K ﹤0.01% 2811
2016
Q2
$462K Buy
90,213
+24,900
+38% +$128K ﹤0.01% 2821
2016
Q1
$267K Buy
65,313
+3,100
+5% +$12.7K ﹤0.01% 3009
2015
Q4
$505K Sell
62,213
-4,400
-7% -$35.7K ﹤0.01% 2735
2015
Q3
$562K Sell
66,613
-25,034
-27% -$211K ﹤0.01% 2587
2015
Q2
$862K Sell
91,647
-5,466
-6% -$51.4K ﹤0.01% 2525
2015
Q1
$899K Buy
97,113
+20,000
+26% +$185K ﹤0.01% 2363
2014
Q4
$713K Sell
77,113
-7,000
-8% -$64.7K ﹤0.01% 2306
2014
Q3
$751K Sell
84,113
-59,185
-41% -$528K ﹤0.01% 2167
2014
Q2
$1.13M Sell
143,298
-77,315
-35% -$607K ﹤0.01% 2005
2014
Q1
$1.75M Buy
220,613
+1,700
+0.8% +$13.4K ﹤0.01% 1841
2013
Q4
$1.36M Buy
218,913
+8,800
+4% +$54.8K ﹤0.01% 1933
2013
Q3
$744K Buy
210,113
+10,300
+5% +$36.5K ﹤0.01% 2140
2013
Q2
$390K Buy
+199,813
New +$390K ﹤0.01% 2325